Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,170 | 54,557 | 37,833 | 11,065 | 43,020 |
| Marketable Securities | 141,070 | 161,552 | 186,819 | 216,275 | 189,865 |
| Receivables | 8,167 | 7,608 | 9,291 | 13,087 | 8,209 |
| Inventories | 12,533 | 11,020 | 10,265 | 8,581 | 7,912 |
| TOTAL | $214,339 | $236,619 | $246,440 | $252,266 | $252,282 |
| Non-Current Assets | |||||
| PPE Net | 23,772 | 24,325 | 24,948 | 23,725 | 22,988 |
| Investments And Advances | 18,429 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 10,187 | 10,261 | 10,157 | 10,662 | 11,142 |
| TOTAL | $52,388 | $34,585 | $35,105 | $34,387 | $34,130 |
| Total Assets | $266,727 | $271,204 | $281,544 | $286,653 | $286,412 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 447 | 1,603 | 3,502 | 292 | 2,087 |
| Accrued Expenses | 9,918 | 6,411 | 6,913 | 8,265 | 8,232 |
| TOTAL | $16,649 | $13,205 | $16,639 | $15,427 | $16,763 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,586 | 4,693 | 5,749 | 6,713 | 6,292 |
| Other Non-Current Liabilities | 16,702 | 17,017 | 17,086 | 17,258 | 14,872 |
| TOTAL | $16,702 | $17,017 | $17,086 | $17,258 | $15,216 |
| Total Liabilities | $33,351 | $30,221 | $33,726 | $32,685 | $31,980 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,576 | 103,505 | 103,051 | 102,905 | 102,047 |
| Common Shares | 1,036 | 1,031 | 1,029 | 1,024 | 1,019 |
| Retained earnings | -170,521 | -159,269 | -148,757 | -137,875 | -133,066 |
| TOTAL | $233,377 | $240,983 | $247,819 | $253,968 | $254,432 |
| Total Liabilities And Equity | $266,727 | $271,204 | $281,544 | $286,653 | $286,412 |